Abstract
Graft-vs-host disease (GVHD) is an unwanted complication of stem cell transplant, but the graft-vs-leukemia (GVL) effect has been shown to positively affect outcomes. GVHD and GVL have similar but not identical alloreactivity, and GVL may be affected by the source of grafts, the preparative conditioning regimen, and donor genetic elements. Human leukocyte antigen (HLA) mismatch does not appear to augment the GVL effect, and increased GVHD does not necessarily lead to decreased relapse.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 525-528 |
| Number of pages | 4 |
| Journal | Best Practice and Research: Clinical Haematology |
| Volume | 23 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute leukemia
- Conditioning regimen
- Cord blood
- GVHD
- GVL
- Graft-vs-host disease
- Graft-vs-leukemia effect
- HLA
- Human leukocyte antigen
- Mismatch
- Unrelated donor
Fingerprint
Dive into the research topics of 'How closely related is graft-vs-leukemia to donor/recipient disparity?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS